GW Pharma (GWPH) has the distinction of having the first cannabis-derived prescription drug that was approved by the FDA: Epidiolex. This drug is …
There’s a new FDA-approved cannabis-based medicine on the scene. Today, the U.
In a research report released on Friday, Goldman Sachs top analyst Salveen Richter initiated coverage on shares of GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) with a …
Cowen analyst Phil Nadeau reiterated an Outperform rating on GW Pharmaceuticals (NASDAQ:GWPH) with a price target of $110, following the news that the company’s first Phase …
In a research report published today, Piper Jaffray analyst Joshua Schimmer maintained an Overweight rating on GW Pharmaceuticals (NASDAQ:GWPH) with a price target of $147, …
